CD44 and cancer: TMB, MSI have been proposed to correlate with response to immunitherapy24, and we intend to evaluate the TMB and MSI status in CD44 expression to determine the potential of CD44 in reflecting the efficacy of immunotherapy to give suggestions on medication for cancer patients.